Warning!
Your browser does not support HTML5.
Display of the content may be incorrect. Please make sure that your browser supports HTML5 syntax.
Search for Small Molecules by SMILES, name, CAS, MFCD, ID, InChI Key
Search for Biologics by ID, Target name, CAS, Protein name, Gene ID, Clone ID, Source Organism
0
0.00 $
Currency
Home CSSS00160476737

Structure Info

Chemspace ID
CSSS00160476737 (In-Stock Screening Compounds)
MFCD
MFCD21363632, MFCD09038742
IUPAC Name
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)(1,1,2,2,3,3-²H₆)propoxy]quinazolin-4-amine
Mol formula
C22H24ClFN4O3
Mol weight
453 Da
Catalog Number(s)
22364, AA01EPO7, AG01EPQZ, AR01EQFZ, AX65971, CSC160476737, G14127, G304008, HY-50895S1, TMIJ-0147, Y3309922

Properties

LogP
3.75
Heavy atoms count
31
Rotatable bond count
8
Number of rings
4
Carbon bond saturation, Fsp3
0.363
Polar surface area (Å)
69
Hydrogen bond acceptors count
7
Hydrogen bond donors count
1

SDS

Choose Language:

If you wish to request SDS before ordering, please contact us at [email protected]

C22H24ClFN4O3
Zoom the structure
CSSS00160476737
 

Items Overall 2 items from 2 suppliers

SupplierLead timeShips fromPurityPackPrice, $Qty
MedChemExpress10 daysUnited States
To:
981 mg558
Go to cartEnquire
Description: Names: Gefitinib-d6; ZD1839-d6; Product Description: Gefitinib-d 6 is the deuterium labeled Gefitinib. Gefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy. Gefitinib has antitumour activity; Target: Autophagy;EGFR; CAS: 1228664-49-0
MedChemExpress EU10 daysSweden
To:
981 mg588
Go to cartEnquire
Description: Names: Gefitinib-d6; ZD1839-d6; Product Description: Gefitinib-d6 is the deuterium labeled Gefitinib. Gefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy. Gefitinib has antitumour activity; Target: Autophagy;EGFR; CAS: 1228664-49-0
For a custom pack size or bulk
please drop us a line:Enquire